VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
This Quarter Return
+7.74%
1 Year Return
+24.65%
3 Year Return
+82.72%
5 Year Return
+113.39%
10 Year Return
–
AUM
$2.9B
AUM Growth
+$2.9B
(-5.8%)
Cap. Flow
-$355M
Cap. Flow
% of AUM
-12.23%
Top 10 Holdings %
Top 10 Hldgs %
11.95%
Holding
1,370
New
137
Increased
551
Reduced
478
Closed
195
Top Buys
| 1 |
T-Mobile US
TMUS
|
$15.6M |
| 2 |
Philip Morris
PM
|
$13.9M |
| 3 |
Altria Group
MO
|
$13.4M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
$13.4M |
| 5 |
Hubbell
HUBB
|
$10.7M |
Top Sells
| 1 |
Apple
AAPL
|
$68.6M |
| 2 |
Visa
V
|
$21.4M |
| 3 |
Adobe
ADBE
|
$16.8M |
| 4 |
Accenture
ACN
|
$13.2M |
| 5 |
PACCAR
PCAR
|
$11M |
Sector Composition
| 1 | Technology | 23.76% |
| 2 | Healthcare | 13.07% |
| 3 | Industrials | 12.01% |
| 4 | Consumer Discretionary | 10.67% |
| 5 | Financials | 9.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
FNB Corp
FNB
$5.92B
| – | – |
-10,469
| Closed | -$121K |
|
1302
Fidelity National Financial
FNF
$16.2B
| – | – |
-11,557
| Closed | -$404K |
|
1303
Fox Class A
FOXA
$26.8B
| – | – |
-40,479
| Closed | -$1.38M |
|
1304
Fortive
FTV
$15.9B
| – | – |
-24,448
| Closed | -$1.67M |
|
1305
Genpact
G
$7.88B
| – | – |
-9,844
| Closed | -$455K |
|
1306
Gen Digital
GEN
$18.3B
| – | – |
-15,660
| Closed | -$269K |
|
1307
Globe Life
GL
$11.4B
| – | – |
-4,492
| Closed | -$494K |
|
1308
Global E Online
GLBE
$5.69B
| – | – |
-11,656
| Closed | -$376K |
|
1309
Generac Holdings
GNRC
$10.3B
| – | – |
-68,573
| Closed | -$7.41M |
|
1310
Gentex
GNTX
$6.07B
| – | – |
-14,624
| Closed | -$410K |
|
1311
Guidewire Software
GWRE
$18.5B
| – | – |
-3,891
| Closed | -$319K |
|
1312
Hasbro
HAS
$11.1B
| – | – |
-8,735
| Closed | -$469K |
|
1313
Huntington Ingalls Industries
HII
$10.6B
| – | – |
-3,529
| Closed | -$731K |
|
|
IGMS
1314
DELISTED
IGM Biosciences
IGMS
| – | – |
-38,078
| Closed | -$523K |
|
1315
Immunocore
IMCR
$1.78B
| – | – |
-12,624
| Closed | -$624K |
|
1316
Immatics
IMTX
$662M
| – | – |
-75,841
| Closed | -$523K |
|
1317
Incyte
INCY
$17B
| – | – |
-18,090
| Closed | -$1.31M |
|
1318
Iovance Biotherapeutics
IOVA
$800M
| – | – |
-112,238
| Closed | -$686K |
|
1319
Iron Mountain
IRM
$26.5B
| – | – |
-28,858
| Closed | -$1.53M |
|
|
ITOS
1320
DELISTED
iTeos Therapeutics
ITOS
| – | – |
-32,887
| Closed | -$448K |
|
1321
Invesco
IVZ
$9.68B
| – | – |
-24,568
| Closed | -$403K |
|
1322
Jacobs Solutions
J
$17.1B
| – | – |
-12,508
| Closed | -$1.47M |
|
1323
Janux Therapeutics
JANX
$1.38B
| – | – |
-55,483
| Closed | -$671K |
|
1324
JD.com
JD
$44.2B
| – | – |
-8,689
| Closed | -$381K |
|
1325
Jack Henry & Associates
JKHY
$11.8B
| – | – |
-1,342
| Closed | -$202K |
|